Tandem Diabetes Care Inc (TNDM) stock
TNDMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3030% below fair value
$17.05−0.01 (-0.06%)
Close on Nov 18, 2026Market cap $1.19BP/E –Yield –
Tandem Diabetes Care operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Tandem Diabetes Care's operating income for the twelve months ending Jun 30, 2026 was -$45.80M. For fiscal 2025 it was -$187.26M. The highest annual figure on record is $22.65M in fiscal 2021.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$187.26M | – |
| FY2024 | Dec 31, 2024 | -$99.13M | – |
| FY2023 | Dec 31, 2023 | -$233.23M | – |
| FY2022 | Dec 31, 2022 | -$92.85M | -509.9% |
| FY2021 | Dec 31, 2021 | $22.65M | – |
| FY2020 | Dec 31, 2020 | -$7.96M | – |
| FY2019 | Dec 31, 2019 | -$16.72M | – |
| FY2018 | Dec 31, 2018 | -$44.63M | – |
| FY2017 | Dec 31, 2017 | -$62.94M | – |
| FY2016 | Dec 31, 2016 | -$78.05M | – |
| FY2015 | Dec 31, 2015 | -$69.00M | – |
| FY2014 | Dec 31, 2014 | -$75.66M | – |
| FY2013 | Dec 31, 2013 | -$49.43M | – |
| FY2012 | Dec 31, 2012 | -$33.05M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$13.79M | – |
| Q1 FY2026 | Mar 31, 2026 | -$17.43M | – |
| Q4 FY2025 | Dec 31, 2025 | $8.29M | – |
| Q3 FY2025 | Sep 30, 2025 | -$22.86M | – |
| Q2 FY2025 | Jun 30, 2025 | -$51.81M | – |
| Q1 FY2025 | Mar 31, 2025 | -$120.88M | – |
| Q4 FY2024 | Dec 31, 2024 | -$581.00K | – |
| Q3 FY2024 | Sep 30, 2024 | -$26.09M | – |
| Q2 FY2024 | Jun 30, 2024 | -$30.77M | – |
| Q1 FY2024 | Mar 31, 2024 | -$41.68M | – |
| Q4 FY2023 | Dec 31, 2023 | -$35.06M | – |
| Q3 FY2023 | Sep 30, 2023 | -$31.55M | – |
| Q2 FY2023 | Jun 30, 2023 | -$38.81M | – |
| Q1 FY2023 | Mar 31, 2023 | -$127.82M | – |
| Q4 FY2022 | Dec 31, 2022 | -$17.78M | -239.6% |
| Q3 FY2022 | Sep 30, 2022 | -$47.49M | -715.2% |
| Q2 FY2022 | Jun 30, 2022 | -$12.24M | -325.3% |
| Q1 FY2022 | Mar 31, 2022 | -$15.34M | – |
| Q4 FY2021 | Dec 31, 2021 | $12.74M | -31.7% |
| Q3 FY2021 | Sep 30, 2021 | $7.72M | – |
| Q2 FY2021 | Jun 30, 2021 | $5.43M | – |
| Q1 FY2021 | Mar 31, 2021 | -$3.24M | – |
| Q4 FY2020 | Dec 31, 2020 | $18.66M | +770.4% |
| Q3 FY2020 | Sep 30, 2020 | -$1.01M | – |
| Q2 FY2020 | Jun 30, 2020 | -$12.04M | – |
| Q1 FY2020 | Mar 31, 2020 | -$13.57M | – |
| Q4 FY2019 | Dec 31, 2019 | $2.14M | +282.9% |
| Q3 FY2019 | Sep 30, 2019 | -$6.00M | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.87M | – |
| Q1 FY2019 | Mar 31, 2019 | -$11.00M | – |
| Q4 FY2018 | Dec 31, 2018 | $560.00K | – |
| Q3 FY2018 | Sep 30, 2018 | -$15.71M | – |
| Q2 FY2018 | Jun 30, 2018 | -$14.00M | – |
| Q1 FY2018 | Mar 31, 2018 | -$15.49M | – |
| Q4 FY2017 | Dec 31, 2017 | -$9.58M | – |
| Q3 FY2017 | Sep 30, 2017 | -$13.17M | – |
| Q2 FY2017 | Jun 30, 2017 | -$18.97M | – |
| Q1 FY2017 | Mar 31, 2017 | -$21.23M | – |
| Q4 FY2016 | Dec 31, 2016 | -$13.35M | – |
| Q3 FY2016 | Sep 30, 2016 | -$28.41M | – |
See a number that looks wrong?